Today is Clinical Trials Day and we would like to raise awareness of the importance of clinical trials and research in Australia, New Zealand, and around the world. We would also like to spotlight the vital role that clinicians and researchers play in conducting this life-changing research.
MS researchers have conducted a three-year follow up of a cutting-edge clinical trial from 2018, which targetted EBV in people with progressive MS.
The International Progressive MS Alliance planned a study to identify and highlight the symptoms that are the most important to people with progressive MS. . These four symptoms included fatigue, mobility and hand/arm function, pain and cognition (memory and thinking).
Rohan Greenland, CEO of MS Australia, shares why he will be participating in The May 50K this year, along with his recent meetings with the MS community.
Connie Baker is taking part in The May 50K this year after being diagnosed with paediatric MS just six months ago at just 9 years old.
This year’s budget returns us to the annual May budget cycle with a focus on the long-term, following
“Nobody wants to get a phone call from their doctor on Good Friday. It’s never good news.” It
Disease-modifying therapies (DMTs) are used in MS to target the immune system, but do these DMTs also diminish a person’s capacity to fight infection?
New Australian research has shed light on unique changes in B cells in women with MS, creating avenues for understanding why MS affects more women than men.
